July 2021
David B. and Bryan I. won second and third place respectively at Immuno-Oncology Young Investigators' Form (IOYIF).


May 2021
Congratulations to Peyton W. and Min L. for graduating with their MSc in Immunology!

A warm welcome to our Wu Lab Summer Group: Naomi, Kira, and Christina.


December 2020
Cathy G., Elisa t.H., Erin P., and Livius P. received ASH Abstract Achievement Awards

Elisa t. H. awarded ASH Scholar Award: Fellow to Faculty and Best of ASH for "Multiplexed CRISPR in vivo editing of CLL loss-of-function lesions models transformation of chronic lymphocytic leukemia into Richter’s syndrome"


October 2020
E.t.H published “High throughput single-cell detection of multiplex CRISPR-edited gene modifications” in Genome Biology; the manuscript reports on her exciting new methodologies for single-cell DNA-sequencing on the Mission Bio Tapestri of murine cell lines edited via CRISPR-Cas9! Check it out on the “Cancer Evolution and Metastasis” special issue:


August 2020
Bryan I. and Erin P. receive the Conquer Cancer Foundation/Sontag Foundation Young Investigator Award.

Bryan I. awarded an NCI K12 Paul Calabresi Career Award


July 2020
Cathy Wu named Lavine Family Chair for Preventative Cancer Therapies


June 2020
Cathy G. passes her Dissertation Defense


May 2020
Nathan D. joined the Wu lab


April 2020
Christina E. is accepted into Boston University's PiBS graduate program


March 2020
Bryan I. awarded 2020 ASCO Meeting Merit Award


April 2020
Nicoletta C. awarded the 2020 AACR Immuno-oncology Research Fellowship for “Addressing AML with vaccine-induced polyclonal leukemia-specific T cells”

Cathy G. received the AY21 MD-PhD DFCI Fellowship Award

Eryn B. joined the Wu lab

David B. awarded two grants by the Department of Defense: “Understanding CD8+ T-Cell Specificity and Function in Renal Cell Carcinoma” and “Combining Locally Administered Ipilimumab with a Personalized Neoantigen Cancer Vaccine to Improve T-Cell Priming and Antitumor Immunity in High-Risk Renal Cell Carcinoma”


March 2020
Match Day!
Donna L. matched to UCSF for internal medicine residency
Patrick L. matched to Cedars-Sinai Medical Center for internal medicine residency


February 2020
Nick S. joined the Wu lab

Donna L. defended MD thesis

Elisa tH. is invited to be part of the iWCLL YIM Program Committee for iWCLL 2021 in Krakow, Poland


January 2020
Peyton W. joined the Wu lab, coming from the Masters of Medical Science (MMSc) at Harvard Medical School

David B. was interviewed by OncLive, discussing the evolution of immunotherapy in advanced renal cell carcinoma


December 2019
Several of our lab members gave presentations at ASH 2019 in Orlando, FL:

Cathy G. interviewed at ASH 2019


November 2019
Elisa tH. presented at 2nd Postgraduate CLL Conference in Bologna, Italy.

David B. presented at the Kidney Cancer Research Summit in Philadelphia, PA: “Using Single Cell Transcriptomics to understand tumor and immune heterogeneity driving resistance and to rationally select immune therapy in advanced RCC”


October 2019
Livius P. began Research Fellowship from German Research Foundation

David B. awarded Career Enhancement Program grant from the DF/HCC Kidney Cancer SPORE

Cathy W., Elisa tH., and Cathy G. presented at iwCLL2019 in Edinburgh, Scotland
Cathy G. received the Young Investigator Scholarship Award.

David B. presented at the International Kidney Cancer Symposium in Miami, FL

Erin P. awarded DDCF Physician Scientist Fellowship


July 2019
Cathy G. received the Melvin Dennis Travel Award to present at the 2019 Annual MD/PhD Conference

David B. awarded Innovate Research Award for Advanced Kidney Cancer by UroToday

Erin P. awarded DFCI Flames FLAIR Fellowship in Lymphoma/Leukemia Research, 2019


June 2019
Anat B. awarded fellowship by the Leukemia & Lymphoma Society


May 2019
David B. named as Next Generation Innovator by HemOnc Today


April 2019
Cathy G. awarded the NIH grant, Ruth L. Kirschtein National Research Service Award, F31 Diversity for “Impact of RPS15 mutation on a development and progression of chronic lymphocytic leukemia” (2019-2023)

For older news, please see the archive.